Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry

Paweena Kreunin, Chul Yoo, Virginia Urquidi, David M. Lubman, Steven Goodison

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Proteomic profiling of an experimental tumor metastasis model has the potential to identify gene products that can influence this fatal phenotype of tumor cells. In this study, we focused on the notoriously difficult to assess ribosomal protein component of a pair of cell lines which originate from the same tumor but have opposite metastatic capabilities. Materials and Methods: Cell lysate proteins were separated using a two-dimensional liquid chromatographic system directly coupled to an ESI-TOF mass spectrometer for accurate intact protein MW analysis. Characterization of distinct post-translational modifications and sequence variation within several ribosomal proteins was obtained using monolithic capillary LC/MS/MS, MALDI-MS and -MS/MS. Results: The combination of these techniques enabled the identification of 45 unique ribosomal proteins, several of which were differentially expressed in metastatic M4A4 cells. Conclusion: The described proteomic profiling approach enables the identification of phenotype-associated ribosomal proteins for subsequent functional analyses and disease biomarker development.

Original languageEnglish (US)
Pages (from-to)329-339
Number of pages11
JournalCancer Genomics and Proteomics
Volume4
Issue number5
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Ribosomal Proteins
Liquid chromatography
Liquid Chromatography
Mass spectrometry
Mass Spectrometry
Neoplasm Metastasis
Tumors
Proteomics
Cells
Phenotype
Neoplasms
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Biomarkers
Mass spectrometers
Post Translational Protein Processing
Proteins
Genes
Cell Line
Liquids

Keywords

  • Cancer biomarkers
  • Electrospray ionization time-of-flight mass spectrometry
  • Liquid chromatography
  • Monolith
  • Ribosomal proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry. / Kreunin, Paweena; Yoo, Chul; Urquidi, Virginia; Lubman, David M.; Goodison, Steven.

In: Cancer Genomics and Proteomics, Vol. 4, No. 5, 01.01.2007, p. 329-339.

Research output: Contribution to journalArticle

@article{3fa5b94a4af64afe830cae77782c9018,
title = "Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry",
abstract = "Background: Proteomic profiling of an experimental tumor metastasis model has the potential to identify gene products that can influence this fatal phenotype of tumor cells. In this study, we focused on the notoriously difficult to assess ribosomal protein component of a pair of cell lines which originate from the same tumor but have opposite metastatic capabilities. Materials and Methods: Cell lysate proteins were separated using a two-dimensional liquid chromatographic system directly coupled to an ESI-TOF mass spectrometer for accurate intact protein MW analysis. Characterization of distinct post-translational modifications and sequence variation within several ribosomal proteins was obtained using monolithic capillary LC/MS/MS, MALDI-MS and -MS/MS. Results: The combination of these techniques enabled the identification of 45 unique ribosomal proteins, several of which were differentially expressed in metastatic M4A4 cells. Conclusion: The described proteomic profiling approach enables the identification of phenotype-associated ribosomal proteins for subsequent functional analyses and disease biomarker development.",
keywords = "Cancer biomarkers, Electrospray ionization time-of-flight mass spectrometry, Liquid chromatography, Monolith, Ribosomal proteins",
author = "Paweena Kreunin and Chul Yoo and Virginia Urquidi and Lubman, {David M.} and Steven Goodison",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "329--339",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry

AU - Kreunin, Paweena

AU - Yoo, Chul

AU - Urquidi, Virginia

AU - Lubman, David M.

AU - Goodison, Steven

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Background: Proteomic profiling of an experimental tumor metastasis model has the potential to identify gene products that can influence this fatal phenotype of tumor cells. In this study, we focused on the notoriously difficult to assess ribosomal protein component of a pair of cell lines which originate from the same tumor but have opposite metastatic capabilities. Materials and Methods: Cell lysate proteins were separated using a two-dimensional liquid chromatographic system directly coupled to an ESI-TOF mass spectrometer for accurate intact protein MW analysis. Characterization of distinct post-translational modifications and sequence variation within several ribosomal proteins was obtained using monolithic capillary LC/MS/MS, MALDI-MS and -MS/MS. Results: The combination of these techniques enabled the identification of 45 unique ribosomal proteins, several of which were differentially expressed in metastatic M4A4 cells. Conclusion: The described proteomic profiling approach enables the identification of phenotype-associated ribosomal proteins for subsequent functional analyses and disease biomarker development.

AB - Background: Proteomic profiling of an experimental tumor metastasis model has the potential to identify gene products that can influence this fatal phenotype of tumor cells. In this study, we focused on the notoriously difficult to assess ribosomal protein component of a pair of cell lines which originate from the same tumor but have opposite metastatic capabilities. Materials and Methods: Cell lysate proteins were separated using a two-dimensional liquid chromatographic system directly coupled to an ESI-TOF mass spectrometer for accurate intact protein MW analysis. Characterization of distinct post-translational modifications and sequence variation within several ribosomal proteins was obtained using monolithic capillary LC/MS/MS, MALDI-MS and -MS/MS. Results: The combination of these techniques enabled the identification of 45 unique ribosomal proteins, several of which were differentially expressed in metastatic M4A4 cells. Conclusion: The described proteomic profiling approach enables the identification of phenotype-associated ribosomal proteins for subsequent functional analyses and disease biomarker development.

KW - Cancer biomarkers

KW - Electrospray ionization time-of-flight mass spectrometry

KW - Liquid chromatography

KW - Monolith

KW - Ribosomal proteins

UR - http://www.scopus.com/inward/record.url?scp=35948931395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35948931395&partnerID=8YFLogxK

M3 - Article

C2 - 17993717

AN - SCOPUS:35948931395

VL - 4

SP - 329

EP - 339

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 5

ER -